European Archives - Page 39 of 1044 - European Medical Journal

AI Assistance Enables Novices to Achieve Diagnostic-Quality Lung Ultrasound Images

AI proven useful in aiding novice users lung ultrasound (LUS) acquire diagnostic-quality images in new studies.

Mapping Cognitive States: A New Frontier in Brainwave Research

Discover how new personalised brain models reveal the link between brainwaves, cognition, and individual neural dynamics.

Persistent DNA Lesions Contribute to Mutations Over Time

A study reveals DNA lesions that persist in stem cells, contributing to mutations, with implications for blood cancers.

New Study Highlights Benefits of Sotagliflozin in Type 1 Diabetes with CKD

Sotagliflozin offers significant benefits for individuals with Type 1 diabetes and chronic kidney disease, study finds.

Innovative Approach to Treat Severe Cow’s Milk Allergy

A recent study explored a baked milk oral immunotherapy protocol for children with severe cow’s milk allergy.

Janet Abrahm

Onc Now: Episode 9: The Power of Palliative Care

Janet Abrahm, Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute breaks stigmas around palliative care and supportive oncology.

FDA fast-tracks brelovitug for treatment of chronic hepatitis D

The drug has been granted Breakthrough Therapy designation by the FDA for the treatment of chronic hepatitis delta (CHD).

3D Printing Revolutionises Neurogenic Bladder Surgery

A recent study introduced a novel approach combining preoperative 3D printing with intraoperative ultrasound-guided puncture to address challenges in neurogenic bladder surgery.

Phase 2 Trial Results: TAK-071 Enhances Cognition in Parkinson’s Disease

TAK-071 enhances cognition in Parkinson’s disease but doesn’t reduce gait variability, phase 2 trial results reveal.

New Model Predicts Gastrointestinal Lesions in Eosinophilic Granulomatosis with Polyangiitis

A new study develops a model to predict gastrointestinal lesions in eosinophilic granulomatosis, highlighting eosinophils as a critical risk factor.